Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Net Sales	$ 20,139,849	$ 11,667,579
Cost of Goods Sold	16,101,555	7,569,193
Gross Profit	4,038,294	4,098,386
Operating Expenses
Research and development	319,167	53,408
Selling general and administrative	14,804,068	11,341,712
Loss on impairment of goodwill and intangible assets	6,993,075	0
Total Operating Expenses	22,116,310	11,395,120
Operating Loss	(18,078,016)	(7,296,734)
Other Income (Expense)
Change in Fair Market Value of Warrant Liability	58,276	66,862
Interest expense	(290,341)	0
Loss on change in Fair Market Value of Contingent Consideration	(240,000)	(574,000)
Gain on Settlement of Contingent Consideration (Note 2)	1,700,000	0
Other Income	274,764	24,871
Forgiveness of paycheck protection program loan	0	296,827
Total Other Income (Expense)	1,502,699	(185,440)
Loss Before Provision for Income Taxes	(16,575,317)	(7,482,174)
Benefit from Income Taxes	0	(91,819)
Net Loss	(16,575,317)	(7,390,355)
Net Loss attributable to common stockholders:
Dividends to preferred shareholders	(1,449,000)	(603,750)
Net Loss attributable to common stockholders	$ (18,024,317)	$ (7,994,105)
Basic and Diluted Loss Per Common Share	$ (1.41)	$ (0.86)
Weighted Average Shares Outstanding - basic and diluted	12,754,979	9,273,257